Company: HCTI
Filing Date: 2025-11-25
Form Type: 424B3
Source: 0001213900-25-114840
Chunk: 20

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-25
Form: 424B3
Chunk 20
---
 the price of our shares of Common Stock. Such proceeds may also be placed in investments that do not produce income or that lose value. The failure to use such funds by us effectively could have a material adverse effect on our business, financial condition, operating results and cash flow.

<div align='center'>11</div>

You may experience future dilution as a result of issuance of the Shares, future equity offerings by us and other issuances of our Common Stock or other securities. In addition, the issuance of the Shares and future equity offerings and other issuances of our Common Stock or other securities may adversely affect our Common Stock price.

In order to raise additional capital, we may in
the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock at prices
that may not be the same as the price per share as prior issuances of Common Stock. We may not be able to sell shares or other securities
in any other offering at a price per share that is equal to or greater than the price per share previously paid by investors, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which
we sell additional shares of our Common Stock or securities convertible into Common Stock in future transactions may be higher or lower
than the prices per share for previous issuances of Common Stock or securities convertible into Common Stock paid by certain investors.
In addition, the exercise price of the Warrants for the Warrant Shares may be or greater than the price per share previously paid by certain
investors. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the issuance of shares of Common Stock
under our equity incentive programs. In addition, the issuance of the Shares and any future sales of a substantial number of shares of
our Common Stock in the public market, or the perception that such sales may occur, could adversely affect the price of our Common Stock.
We cannot predict the effect, if any, that market sales of those shares of Common Stock or the availability of those shares for sale will
have on the market price of our Common Stock.

Substantial future sales of shares of our Common Stock could cause the market price of our Common Stock to decline.

We expect that significant additional capital
will be needed in the near future to continue our planned operations. Sales of a substantial number of shares of our Common Stock in the
public market, or the perception that these sales might occur, could depress the market